Mesh Bio Pte.
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- $7.1M
Investors
- 7
About Mesh Bio Pte.
Founded in 2018 by Andrew Wu, Arsen Batagov, and Melvin Heng, and based in Singapore, Mesh Bio Pte. Ltd. is a digital healthtech startup that offers a Health Intelligence Platform designed to improve patient care through systems biology and predictive analytics.VC, and Startup Creasphere. In January 2024, Mesh Bio Pte. Ltd.vc and SEEDS Capital. The firm provides clinical decision support and intervention guidance, leveraging AI analytics and scientific data. Mesh Bio's solutions aid healthcare providers in transforming health screening and chronic disease management, facilitating digital transformation via clinical workflow automation and predictive analytics. They enhance patient engagement by offering personalized health insights and risk predictions. Additionally, Mesh Bio supports pharmaceutical development by uncovering pharmacodynamics and identifying novel therapeutic interventions. Their focus includes managing chronic diseases such as cardiovascular conditions, hypertension, diabetes, fatty liver, kidney disease, myocardial infarction, and stroke.
Who invested in Mesh Bio Pte.
7 investors across 4 rounds
See all investors in Mesh Bio Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mesh Bio Pte.
Who invested in Mesh Bio Pte.?
Mesh Bio Pte. has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mesh Bio Pte. raised?
Mesh Bio Pte. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Mesh Bio Pte. last raise money?
Mesh Bio Pte.'s most recent round on record is a Series A, in Mar 2024.
What does Mesh Bio Pte. do?
Founded in 2018 by Andrew Wu, Arsen Batagov, and Melvin Heng, and based in Singapore, Mesh Bio Pte.
Where is Mesh Bio Pte. headquartered?
Mesh Bio Pte. is headquartered in Singapore.
Which VCs invest in companies like Mesh Bio Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at Mesh Bio Pte.'s stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Mesh Bio Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.